FDA Approves Spinraza (nusinersen) for Spinal Muscular Atrophy

December 23, 2016 -- The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news